MedLife Group, the leading private healthcare provider in Romania, has introduced the EarlyCDT® test, a blood-based immunologic test for the early detection of lung cancer. It identifies autoantibodies produced by the body up to 4 years before visible lesions appear. The test is non-invasive and is mainly targeted at people with risk factors, with a turnaround time of about 15 days. Studies show that the use of this test reduces late-stage diagnoses by 36%, increasing the chances of survival. MedLife reaffirms its commitment to innovation in laboratory medicine.
Sources
MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
Inovație în medicina de laborator: MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
Latest News
16:20
Ukraine becomes a provider of assistance within the EU Civil Protection Mechanism, sending 70 firefighters to France to help extinguish the fires.
16:10
Reactor 2 of the nuclear power plant in Cernavodă can operate for four to five days due to the low flow of the Danube. Authorities are discussing measures to divert water and save energy.
16:00
A ship of the Russian nuclear agency Rosatom, Yanina, was sunk by a Ukrainian drone attack in the Black Sea.
15:50
Twenty-two member states of the European Union, including Romania, are requesting an urgent videoconference to discuss measures against illegal immigration, following the crisis in Ceuta.
15:37
Over 300 firefighters are intervening on Saturday to save the Porto Germeno resort, affected by strong fires in the Gulf of Corinth.
See more news